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Abstract
Background: A recent genome-wide association study (GWAS) identified susceptibility loci for dengue shock syndrome
(DSS) at MICB rs3132468 and PLCE1 rs3740360. The aim of this study was to define the extent to which MICB (rs3132468) and
PLCE1 (rs3740360) were associated with less severe clinical phenotypes of pediatric and adult dengue.
Methods: 3961 laboratory-confirmed dengue cases and 5968 controls were genotyped at MICB rs3132468 and PLCE1
rs3740360. Per-allele odds ratios (OR) with 95% confidence intervals (CI) were calculated for each patient cohort. Pooled
analyses were performed for adults and paediatrics respectively using a fixed effects model.
Results: Pooled analysis of the paediatric and adult cohorts indicated a significant association between MICB rs3132468 and
dengue cases without shock (OR = 1.15; 95%CI: 1.07 – 1.24; P = 0.0012). Similarly, pooled analysis of pediatric and adult
cohorts indicated a significant association between dengue cases without shock and PLCE1 rs3740360 (OR = 0.92; 95%CI:
0.85 – 0.99; P = 0.018). We also note significant association between both SNPs (OR = 1.48; P = 0.0075 for MICB rs3132468
and OR = 0.75, P = 0.041 for PLCE1 rs3740360) and dengue in infants.
Discussion: This study confirms that the MICB rs3132468 and PLCE1 rs3740360 risk genotypes are not only associated with
DSS, but are also associated with less severe clinical phenotypes of dengue, as well as with dengue in infants. These findings
have implications for our understanding of dengue pathogenesis.
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Introduction
Dengue is the most important arboviral disease of humans.[1]
Dengue viruses (DENV) cause a spectrum of clinical manifesta-
tions ranging from asymptomatic infection through to life-
threatening shock and haemorrhage.[1,2] The clinical outcome
of an individual infection is influenced by a variety of virus and
host-related factors. The host factors that influence the clinical
course of an individual infection include flavivirus infection
history, host genotype, sex, age, and the presence of underlying
medical conditions.[3–5] The first GWAS in dengue identified
susceptibility loci for dengue shock syndrome (DSS) at MHC class
I polypeptide-related sequence B (MICB) (C/T, rs3132468) on
chromosome 6 and phospholipase C, epsilon 1 (PLCE1) (C/A,
rs3740360) on chromosome 10.[6] The MICB gene encodes an
activating ligand of natural killer (NK) cells (and possibly CD8+ T
cells). We have previously speculated that mutations in MICB
might result in impaired induction of anti-viral effector functions
in NK cells with the consequence being a greater DENV-infected
cell mass in vivo [6], a recognised risk factor for severe dengue.[7]
The identification of variants of PLCE1 as being associated with
severe dengue is intriguing.[6] Rare mutations of high penetrance
within PLCE1 are associated with nephrotic syndrome, a condition
characterised by oedema secondary to proteinuria and reduced
vascular oncotic pressure.[8] Since plasma leak, proteinuria and
hypovolemia are also characteristic features of severe dengue, it’s
plausible that nephrotic syndrome and severe dengue share some
common underlying pathophysiological processes. Furthermore,
there are data implicating PLCE1 in the homeostatic regulation of
blood pressure.[9] These findings have the potential to help us
define more clearly the functional basis of PLCE1 variants in
severe dengue.
The SNP associations identified at MICB (rs3132468) and
PLCE1 (rs3740360) by the GWAS study were in the context of
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pediatric patients with DSS, leaving unanswered the question
whether they are also associated with less severe clinical
phenotypes of dengue. To this end, the aim of this study was to
define the extent to which these alleles were associated with milder
clinical phenotypes of pediatric and adult dengue. We analyzed a
total of 3961 laboratory-confirmed dengue cases, independent
from the initial GWAS study, and 5968 cord blood controls.[6]
Materials and Methods
Ethics statement
All participants gave written informed consent to participate in
the prospective studies summarised in Table 1 (details of the
inclusion and exclusion criteria are available in Supplementary
Table 1). Parents or guardians provided written informed consent
on behalf of the children involved in the studies. The protocols for
these studies were approved by the Institutional Review Boards of
each study site (Hospital for Tropical Diseases HCMC, Children’s
Hospital 1 and 2 HCMC, Hung Vuong Hospital HCMC, Dong
Thap Hospital, Sa Dec Hospital and Tien Giang Hospital) and by
the Oxford University Tropical Research Ethics Committee. Each
ethical committee approved of the consent procedure detailed
above.
Enrolment and diagnosis
Blood samples for genotyping were collected in one of several
prospective studies of dengue in Vietnamese patients detailed in
Table 1. Dengue cases were laboratory-confirmed by one of three
methods: IgM-seroconversion by ELISA assay on paired samples,
detection of DENV RNA by RT-PCR, or detection of non-
structural protein 1 (NS1) by ELISA (BioRad Platelia). The control
samples used in this study were from blood samples collected from
the umbilical cord of newborn infants enrolled into the birth
cohort study detailed in Table 1. Within each cohort, dengue cases
were classified in a binary fashion as being ‘‘DSS’’ or ‘‘not-
DSS’’.[6] Consistent with the original GWAS study, DSS cases
were defined as laboratory-confirmed dengue cases with cardio-
vascular decompensation secondary to plasma leakage and
requiring fluid resuscitation.[2]
Genotyping
DNA extractions were performed using a MagNA Pure 96
DNA and Viral NA Small Volume Kit (Roche, Germany)
according to the manufacturer’s instructions. Candidate SNPs
were genotyped using a TaqManH genotyping assay to amplify and
detect the specific alleles in the DNA samples as per manufacturer
instructions.
Statistical analysis
The data were analysed using PLINK version 1.07 and the R
statistical software package version 2.12.0 (2010 The R Founda-
tion for Statistical Computing). For each cohort study per-allele
odds ratios with 95% confidence intervals were calculated to assess
the relationship between SNP genotypes (rs3132468 at MICB and
rs3740360 at PLCE1) and susceptibility to dengue. For the analysis
we considered non-DSS cases in children separately from adults
and considered infants with dengue as a distinct group. Infants
were defined as less than 1 year in age, children were defined by
ages between 1 and 15 years, and adults were defined by being 16
years and older. Other variables known to be associated with
disease severity were not included in this analysis, consistent with
the GWAS primary analysis for DSS as well as other infectious
diseases.[6,10–12] Pooled odds ratios across the different sample
collections were calculated using the inverse-variance, fixed effects
model, as previously described.[13] This model used the weighted
average of each study’s odds ratio. The weights used were the
inverse of the variance of the study’s estimated odds ratio, ensuring
Table 1. Summary of the cohort studies used in the analysis.
Group Number (% male)
Median age (range 5th –
95th)
Control 1068 (52) At birth
Infants 165 (55) 7 months (3 – 12 months)
DC 59 (52) 6 (3 – 11)
DT 88 (57) 7 (4 – 11)
DZ 8 (50) 8 (7 – 11)
FB 9 (55) 8 (7 – 15)
Children/Young adults 2759 (56) 12 years (6 – 16 years)
FG 576 (56) 11 (4 – 22)
06DX 220 (71) 13 (11 – 14)
DR 582 (56) 11 (6 – 15)
MD 1381 (60) 12 (7 – 14)
Adults 741 (46) 22 (15 – 35)
09DX 159 (41) 23 (19 – 27)
D001 54 (43) 20 (14 – 25)
FL 528 (48) 22 (15 – 35)
doi:10.1371/journal.pone.0059067.t001
Figure 1. Genotyping and sample quality control process
flowchart.
doi:10.1371/journal.pone.0059067.g001
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that larger studies command greater weight. Forest plots
demonstrating these results were created in R.
Results
Case and control cohorts
The patient cohorts that provided the laboratory-confirmed
dengue cases that were genotyped in this study are summarised in
Table 1. Across the 7 cohorts (4 pediatric and 3 adult) there were
297 DSS cases (161 pediatric and 136 adult), 3500 non-DSS
dengue cases (2759 pediatric and 741 adult cases), and 164 cases of
infants with dengue that were successfully genotyped at MICB
rs3132468 and PLCE1 rs3740360. Umbilical cord blood DNA
samples (n = 1068) were similarly genotyped at MICB rs3132468
and PLCE1 rs3740360 and served as population controls. Data
from this was complemented with genotype data from 4900
controls studied previously.[6] In a priori analyses we considered
non-DSS cases in children separately from adults. Infants with
dengue (n = 164) were also treated as a distinct cohort because of
the unique context of dengue in this age group. The sample quality
control process is illustrated in Figure 1.
Association between MICB rs3132468 and dengue in
children and adults
Pooled analysis of genotype data from the pediatric patient
cohorts revealed that non-DSS dengue cases were significantly
more likely to carry the MICB risk allele rs3132468 than controls
(per-allele odds ratio (OR) = 1.16; 95%CI: 1.07 – 1.25). Pooled
analysis of cohorts of adult non-DSS dengue cases revealed a
similar pattern of effect with the MICB risk allele, but this did not
reach statistical significance (OR = 1.10, P = 0.11; Figure 2,
and Table 2). However, a pooled analysis of all pediatric and
adult patient cohorts indicated a significant association (OR =
1.15, P = 0.0014; Figure 2, and Table 2) compared to controls,
with no heterogeneity between children and adults (Phet = 0.19).
In the relatively small number of adult and pediatric DSS cases (N
= 297), we were able to confirm the association and effect size
reported in our previous GWAS (OR = 1.42, P = 0.0014;
Figure 2 and Table 2).
Association between PLCE1 rs3740360 and dengue in
children and adults
We observed significant association with non-DSS cases upon
pooled analysis of all adults and children (OR = 0.92, P = 0.018;
Figure 3 and Table 3). Amongst DSS cases, the association at
PLCE1 revealed by the previous GWAS was confirmed (OR =
0.77: P = 0.0094).
Figure 2. Forest plot illustrating the association between MICB rs3132468 and susceptibility to dengue. 06DX, DR, FG and MD were
cohort studies of children, and 09DX, D001 and FL were cohort studies of adults. The oblongs represent point estimates (referring to the per-allele
odds ratio, expressed on the horizontal axis), with the height of the oblongs inversely proportional to the standard error of the point estimates.
Horizontal lines indicate the 95% confidence interval for each point estimate. Meta-analysis of children, adults, as well as children and adults with
uncomplicated dengue are reflected by blue diamonds. Data from our previously reported GWAS on DSS is reflected by the purple diamond.[6] The
width of the diamonds indicates their 95% confidence intervals. Each meta-analysis is accompanied by a test of heterogeneity between the sample
collections summarized by it (expressed as Phet).
doi:10.1371/journal.pone.0059067.g002
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Association between MICB rs3132468 and dengue in
infants
Since each of the infant cohorts was relatively small in their own
right, a meta-analysis was performed. Consistent with the findings
in older children, this pooled analysis revealed a significant
association between dengue in infants and MICB rs3132468 (OR
= 1.48; P = 0.0075), as well as PLCE1 rs3740360. (OR = 0.75, P
= 0.041) (Figures 2 and 3; Tables 2 and 3). Although the infant
cohorts included 16 cases of DSS, removal of these samples did not
affect the associations demonstrated.
Discussion
MICB rs3132468 and PLCE1 rs3740360 genotypes are
associated with DSS in Vietnamese children.[6] Here, we have
extended this finding by follow-up genotyping in a large number of
Vietnamese adult and paediatric dengue cases, together with a
new cohort of population control samples. The data revealed
significant association between MICB rs3132468 and PLCE1
rs3740360 and clinical phenotypes of dengue less severe than DSS,
albeit with smaller effect sizes than observed between these alleles
and DSS.[6] In addition, we observed association between both
SNP genotypes and infants with dengue at effect sizes comparable
to that seen with DSS. Finally, amongst children and adults with
DSS in these cohorts, we were able to confirm association ofMICB
rs3132468 and PLCE1 rs3740360 that was first observed in the
previous GWAS.[6] Collectively, these findings provide further
validation of the importance of MICB rs3132468 and PLCE1
rs3740360 risk genotypes to shaping the clinical phenotype of
dengue and raises intriguing questions about their roles in disease
pathogenesis.
The association of the MICB rs3132468 genotype with clinical
phenotypes of dengue less severe than DSS indicates a role for this
variant in susceptibility to overall clinically apparent dengue and
not just severe disease. Given the role of MICB in activation of NK
and CD8+ cells these findings support a central role for these cell
types in shaping the outcome of DENV infection. For example, it
is plausible that the MICB rs3132468 genotype is associated with
an impaired NK cell response, potentially resulting in a higher in
vivo virus titre and an increased risk of developing both
symptomatic and severe dengue. Furthermore, inefficient induc-
tion of regulatory NK cells might result in dysregulated T cell
responses that may also shape the clinical phenotype.[14]
The effect size between the PLCE1 rs3740360 risk genotype and
milder clinical phenotypes of dengue was less pronounced than
that observed for DSS cases.[6] Whilst a degree of endothelial leak
is likely to occur in most clinically evident DENV infections,
patients with DSS experience the most severe vascular perme-
ability.[15,16] Our current data, together with the recently
demonstrated association between PLCE1 rs3740360 and DSS,
may indicate a central role for PLCE1 in the context of vascular
leakage.[6] Further genetic fine mapping studies will be required
to pinpoint functional mutations that could mechanistically
explain the association between PLCE1 and DSS. In doing so,
Table 2. Per-collection analysis for MICB rs3132468.
Children
Collection Number MAF cases MAF
controls
OR 95% CI Weight P
06DX 220 0.160 0.134 1.23 0.95 – 1.51 49.45393 0.14
DR 582 0.129 0.134 0.96 0.78 – 1.14 119.4422 0.66
FG 576 0.156 0.134 1.20 1.03 – 1.37 134.8943 0.035
MD 1381 0.159 0.134 1.23 1.12 – 1.35 289.2313 0.00047
All children 2759 0.152 0.134 1.16 1.07 – 1.25 - 0.0011
Adults
Collection Number MAF cases MAF
controls
OR 95% CI Weight P
09DX2 159 0.118 0.134 0.86 0.51 – 1.21 31.03638 0.42
D001 54 0.173 0.134 1.36 0.85 – 1.87 14.72486 0.24
FL 528 0.151 0.134 1.15 0.97 – 1.33 120.2293 0.12
All adults 741 0.145 0.134 1.10 0.94 – 1.26 – 0.22
All mild cases (Adults and children) 3500 0.151 0.134 1.15 1.07 – 1.24 – 0.0014
Collection MAF cases MAF
controls
OR 95% CI Weight P
All infants 164 0.186 0.134 1.48 1.19 – 1.77 – 0.0075
Collection MAF cases MAF
controls
OR 95% CI Weight P
All DSS 297 0.180 0.134 1.42 1.20 – 1.64 – 0.0014
Number: Number of cases
MAF cases: minor allele frequency in dengue cases
MAF controls: minor allele frequency in controls
OR: per-allele odds ratio.
SE: Standard error of the OR
Weight: study-specific weight when meta-analyzed, not calculated for infants and DSS collections, which were not meta-analyzed.
P: P-value for association with disease (unadjusted).
doi:10.1371/journal.pone.0059067.t002
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we expect to contribute to the wider understanding of the role of
PLCE1 in health and disease, particularly in light of its association
with nephrotic syndrome, regulation of blood pressure and
esophageal cancer.[8,9,17] In light of the observed association
with PLCE1 and nephrotic syndrome it is interesting that the
degree of proteinuria has been proposed as a potential predictor in
determining which dengue patients are at risk of developing more
severe disease.[18]
Infants with dengue were analysed independently of other patient
populations. Primary infection in the context of waning maternal
antibody levels, immunological immaturity and vulnerable physiol-
ogy make infants with dengue a distinct group.[19] Our data shows
association between MICB rs3132468 and dengue in infants, with
effect sizes in keeping with that observed in DSS patients.[6] We
speculate that this reflects a prominent role for innate immunity and
particularly NK cells in controlling early viral infection in infants;
impaired control of viral replication could be a risk factor for clinically
apparent dengue in this age group. The effect size observed at PLCE1
rs3740360 was also similar to that observed in DSS patients.[6] It has
been noted that hospitalised infants with dengue represent a group
with the highest risk of death, and it is thought that this is partly
related to an intrinsically more permeable vascular endothelium in
this age group.[4] In infants with dengue, carriage of either risk alleles
thus represent an additional risk variable alongside the presence of
maternally-derived non-neutralising antibodies and poor compensa-
tory reserve.[19–20]
Our study has limitations. Misclassified control samples will be
more common in this study than in the original GWAS of DSS
cases because dengue without shock is a more common clinical
outcome for a given cohort of children in an endemic area.
Reassuringly, the fact that consistent associations were observed
despite this limitation lends credence to our observations. In
addition, as the functional basis of these mutations as yet to be
clearly defined our conclusions are to an extent speculative. As
dengue without shock includes a diverse range of clinical
manifestations our ability to determine this functional basis is
more limited.
We have shown that the MICB rs3132468 and PLCE1 rs3740360
genotypes are associated with clinically apparent dengue in both adults
and children, which is a significant extension from the earlier GWAS
on DSS cases alone. As expected, the effect sizes of these variants is
small and underscores that susceptibility to symptomatic dengue is
multifactorial and includes demographic risk factors (e.g. age).[21]
However, we have not performed multivariate analysis in this study as
the majority of risk factors for symptomatic (non-severe) dengue are not
clearly defined.. The challenge now is to define the functional basis for
these observed genetic associations at MICB and PLCE1 and thus
increase our understanding of disease pathogenesis.
Figure 3. Forest plot illustrating the association between PLCE1 rs3740360 and susceptibility to dengue. 06DX, DR, FG and MD were
cohort studies of children. and 09DX, D001 and FL were cohort studies of adults. The oblongs represent point estimates (referring to the per-allele
odds ratio, expressed on the horizontal axis), with the height of the oblongs inversely proportional to the standard error of the point estimates.
Horizontal lines indicate the 95% confidence interval for each point estimate. Meta-analysis of children, adults, as well as children and adults with
uncomplicated dengue are reflected by blue diamonds. Data from our previously reported GWAS on DSS is reflected by the purple diamond.[6] The
width of the diamonds indicates their 95% confidence intervals. Each meta-analysis is accompanied by a test of heterogeneity between the sample
collections summarized by it (expressed as Phet).
doi:10.1371/journal.pone.0059067.g003
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